When treating AML cell lines in combination with PRI-724, and chemotherapy sorafenib, the combination synergistically induced apoptosis AML cell lines, AML blasts, and FLT3-mutated CD34+CD38− AML stem/progenitor cells. Here, FLT3 is linked to acute myeloid leukemia.